Head-to-head · WeighScore
Care Bare Rx vs ShedRx
The verdict
ShedRx takes it — 87/100 to 75/100.
ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Care Bare Rx | ShedRx |
|---|---|---|
| WeighScore | 75/100 | 87/100 |
| Grade | C | B+ |
| Site position | #60 | #3 |
| Semaglutide | From $199/mo (shared weight-loss price) | $199/mo |
| Tirzepatide | From $199/mo (shared weight-loss price) | $299/mo |
| Coverage | Multi-state | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #60 · C
Strengths
- Oral tirzepatide as well as injectable — rare in this ranking
- Brand Ozempic (from $705/mo) and oral Rybelsus beside the compounded line
- LegitScript certified and HIPAA compliant
- One platform if you also want hair, TRT, sexual health or NAD+
Where it loses points
- The advertised "from $199/mo" is one figure shared across all weight-loss treatments — neither molecule priced separately
- Per-dose pricing is quiz-gated, so a titrated cost cannot be modeled beforehand
- No named clinicians, founding year or parent company disclosed
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
Site position #3 · B+
Strengths
- Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
- Brand Zepbound and Wegovy available beside the compounded line
- Health coaching included with membership, plus a published 120-day weight-loss guarantee
Where it loses points
- The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- The dispensing compounding pharmacy is not publicly named
Featured provider
ShedRx
ShedRx scores 87/100 (B+). The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.